|
시장보고서
상품코드
1786949
항체 탐색 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 방법별, 항체 유형별, 최종 사용자별, 지역별 시장 예측(2025-2034년)Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최근 조사에 따르면, 항체 탐색 시장 규모는 2034년까지 204억 1,000만 달러에 이를 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.
항체 탐색은 바이러스, 세균, 암세포 등의 표적에 특이적으로 결합하는 항체를 확인하고 개발하는 과정입니다. 하이브리드 도마 기술, 퍼지 디스플레이, 단일 B 세포 스크리닝과 같은 기술을 활용하여 효과적인 항체를 분리하고 최적화합니다. 이러한 항체는 진단, 치료 또는 조사에 사용될 수 있으므로 특성 평가되고 검사됩니다.
맞춤형 의료는 개인의 유전적 체질과 병태에 맞는 치료에 초점을 맞추어 질병의 치료 방법을 변화시키고 있습니다. 항체는 암세포에서 볼 수 있는 체내의 특정 분자를 표적으로 하도록 설계할 수 있기 때문에 이 접근법에서 중요한 역할을 하고 있습니다. 보다 정확하고 부작용이 적은 치료를 선호하는 사람들과 의사가 증가함에 따라 맞춤형 항체 치료에 대한 수요가 증가하고 있습니다. 이 이동은 치료에 정확히 동일한 반응을 보이는 환자가 두 명도 없는 종양학과 같은 부문에서 특히 중요합니다. 항체 탐색 기술은 다른 환자 그룹에 맞는 특이성이 높은 치료법을 확인하고 개발할 수 있습니다. 이 동향은 제약 회사가 개인화 접근을 지원하는 조사에 더 많은 투자를 할 것을 촉구합니다. 맞춤형 의료에 대한 인식과 성공 사례가 늘어남에 따라 항체 탐색 시장은 앞으로 나아가 미래의 헬스케어에 필수적입니다.
생명 공학 기업, 제약 선도, 학술 기관 및 실험실 간의 전략적 제휴는 항체 탐색의 진전에 큰 역할을 합니다. 이러한 파트너십을 통해 서로 다른 조직이 자원, 지식, 기술을 공유할 수 있으며, 의약품 프로세스를 보다 빠르고 효과적으로 만들 수 있습니다. 실험실에는 첨단 기술 셋업이 있을 수 있으며 제약 회사는 자금과 제조 능력을 가질 수 있습니다. 공동 연구는 또한 의약품 개발과 관련된 높은 비용과 위험 관리에 도움이 됩니다. 현재 많은 기업들이 이익과 책임을 공유하기 위해 공동 개발과 라이선스 계약을 맺고 있습니다. 이러한 추세는 임상 검사에 들어가고 궁극적으로 환자에게 도달하는 항체 의약품의 수를 증가시킵니다.
항체 탐색 시장 보고서 하이라이트
2024년에는 범용성, 신뢰성, 비교적 단시간에 고친화성 항체를 생산하는 능력으로부터 퍼지 디스플레이 부문이 가장 큰 점유율을 차지했습니다.
제약 바이오테크놀러지 산업 부문은 암, 자가면역질환, 감염증 등 폭넓은 질환을 치료하기 위해 단일클론항체를 포함한 생물제제의 개발에 점점 주력하고 있기 때문에 예측 기간 중에 큰 성장이 예상됩니다.
2024년 북미는 강력한 생물의료 연구 인프라 및 생명과학에 일관된 투자를 통해 항체 탐색 시장에서 가장 큰 점유율을 차지했습니다.
아시아태평양의 항체 탐색 시장은 생명공학산업 확대, 정부 지원책, 헬스케어 연구 투자 증가로 큰 성장을 이루고 있습니다.
세계 주요 시장 진출 기업은 Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics SA, Genscript Technology Corporation, Sartorius AG, Twist Bioscience 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 항체 탐색 시장 인사이트
- 시장 현황
- 항체 탐색 시장 역학
- 성장 촉진요인 및 기회
- 만성질환 및 감염증의 만연
- 바이오의약품 연구개발에 대한 투자 증가
- 성장 억제요인 및 과제
- 제조의 높은 초기 비용
- 성장 촉진요인 및 기회
- PESTEL 분석
- 항체 탐색 시장 동향
- 밸류체인 분석
제5장 세계의 항체 탐색 시장 : 방법별
- 주요 조사 결과
- 서문
- 파지 디스플레이
- 하이브리도마
- 기타
제6장 세계의 항체 탐색 시장 : 항체 유형별
- 주요 조사 결과
- 서문
- 인간화 항체
- 인간 항체
- 키메라 항체
- 마우스 항체
제7장 세계의 항체 탐색 시장 : 최종 사용자별
- 주요 조사 결과
- 서문
- 제약 생명 공학 산업
- 실험실
- 학술 실험실
제8장 세계의 항체 탐색 시장 : 지역별
- 주요 조사 결과
- 서문
- 항체 탐색 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 방법별(2020-2034년)
- 북미 : 항체 유형별(2020-2034년)
- 북미 : 최종 사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 방법별(2020-2034년)
- 유럽 : 항체 유형별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 방법별(2020-2034년)
- 아시아태평양 : 항체 유형별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 방법별(2020-2034년)
- 중동 및 아프리카 : 항체 유형별(2020-2034년)
- 중동 및 아프리카 : 최종 사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 방법별(2020-2034년)
- 라틴아메리카 : 항체 유형별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제10장 기업 프로파일
- Biocytogen
- Charles River Laboratories
- Creative Biolabs
- Danaher Corporation
- Eurofins Scientific
- Evotec
- Fairjourney Biologics SA
- Genscript Technology Corporation
- Sartorius AG
- Twist Bioscience
The antibody discovery market size is expected to reach USD 20.41 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Antibody discovery is the process of identifying and developing antibodies that can specifically bind to a target, such as a virus, bacterium, or cancer cell. It involves techniques such as hybridoma technology, phage display, or single B-cell screening to isolate and optimize effective antibodies. These antibodies are then characterized and tested for their potential use in diagnostics, therapeutics, or research.
Personalized medicine is transforming the way diseases are treated by focusing on therapies that are tailored to an individual's genetic makeup and condition. Antibodies play a key role in this approach as they can be engineered to target specific molecules in the body, such as those found in cancer cells. The demand for customized antibody therapies is rising as more people and doctors prefer treatments that are more precise and have fewer side effects. This shift is especially important in fields such as oncology, where no two patients respond exactly the same way to treatment. Antibody discovery technologies enable the identification and development of highly specific treatments tailored to different patient groups. This trend is encouraging pharmaceutical companies to invest more in research that supports personalized approaches. As awareness and success stories around personalized medicine grow, it pushes the antibody discovery market forward, making it an essential part of future healthcare.
Strategic collaborations between biotech companies, pharmaceutical giants, academic institutions, and research labs are playing a big role in advancing antibody discovery. These partnerships allow different organizations to share resources, knowledge, and technology, making the discovery process faster and more effective. A research lab may have an advanced technological setup, while a pharmaceutical company may have the funding and manufacturing capabilities. Collaborations further help in managing the high cost and risk associated with drug development. Many companies now enter co-development or licensing agreements to share profits and responsibilities. This trend has led to a growing number of antibody-related drugs entering clinical trials and eventually reaching patients.
Antibody Discovery Market Report Highlights
In 2024, the phage display segment dominated with the largest share due to its versatility, reliability, and ability to produce high-affinity antibodies in a relatively short time.
The pharmaceutical and biotechnology industry segment is expected to experience significant growth during the forecast period as these companies are increasingly focused on developing biologic drugs, including monoclonal antibodies, to treat a wide range of conditions such as cancer, autoimmune diseases, and infectious diseases.
In 2024, North America dominated the antibody discovery market with the largest share due to its strong biomedical research infrastructure and consistent investments in life sciences.
The Asia Pacific antibody discovery market is experiencing significant growth driven by expanding biotech industries, supportive government initiatives, and increasing investments in healthcare research.
A few global key market players are Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, and Twist Bioscience.
Polaris Market Research has segmented the antibody discovery market report on the basis of method, antibody type, end user, and region:
By Method (Revenue - USD Billion, 2020-2034)
Phage Display
Hybridoma
Others
By Antibody Type (Revenue - USD Billion, 2020-2034)
Humanized Antibody
Human Antibody
Chimeric Antibody
Murine Antibody
By End User (Revenue - USD Billion, 2020-2034)
Pharmaceutical and Biotechnology industry
Research laboratory
Academic laboratory
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Antibody Discovery Market Insights
- 4.1. Antibody Discovery Market - Market Snapshot
- 4.2. Antibody Discovery Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing Prevalence of Chronic and Infectious Disease
- 4.2.1.2. Increase in Investment in Biopharmaceutical R&D
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Cost of Manufacturing
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Antibody Discovery Market Trends
- 4.6. Value Chain Analysis
5. Global Antibody Discovery Market, by Method
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 5.3. Phage Display
- 5.3.1. Global Antibody Discovery Market, by Phage Display, by Region, 2020-2034 (USD billion)
- 5.4. Hybridoma
- 5.4.1. Global Antibody Discovery Market, by Hybridoma, by Region, 2020-2034 (USD billion)
- 5.5. Others
- 5.5.1. Global Antibody Discovery Market, by Others, by Region, 2020-2034 (USD billion)
6. Global Antibody Discovery Market, by Antibody Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 6.3. Humanized Antibody
- 6.3.1. Global Antibody Discovery Market, by Humanized Antibody, by Region, 2020-2034 (USD billion)
- 6.4. Human Antibody
- 6.4.1. Global Antibody Discovery Market, by Human Antibody, by Region, 2020-2034 (USD billion)
- 6.5. Chimeric Antibody
- 6.5.1. Global Antibody Discovery Market, by Chimeric Antibody, by Region, 2020-2034 (USD billion)
- 6.6. Murine Antibody
- 6.6.1. Global Antibody Discovery Market, by Murine Antibody, by Region, 2020-2034 (USD billion)
7. Global Antibody Discovery Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 7.3. Pharmaceutical and Biotechnology industry
- 7.3.1. Global Antibody Discovery Market, by Pharmaceutical and Biotechnology industry, by Region, 2020-2034 (USD billion)
- 7.4. Research laboratory
- 7.4.1. Global Antibody Discovery Market, by Research laboratory, by Region, 2020-2034 (USD billion)
- 7.5. Academic laboratory
- 7.5.1. Global Antibody Discovery Market, by Academic laboratory, by Region, 2020-2034 (USD billion)
8. Global Antibody Discovery Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
- 8.3. Antibody Discovery Market - North America
- 8.3.1. North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.3.2. North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.3.3. North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.3.4. Antibody Discovery Market - U.S.
- 8.3.4.1. U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.3.4.2. U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.3.4.3. U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.3.5. Antibody Discovery Market - Canada
- 8.3.5.1. Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.3.5.2. Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.3.5.3. Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4. Antibody Discovery Market - Europe
- 8.4.1. Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.2. Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.3. Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.4. Antibody Discovery Market - UK
- 8.4.4.1. UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.4.2. UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.4.3. UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.5. Antibody Discovery Market - France
- 8.4.5.1. France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.5.2. France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.5.3. France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.6. Antibody Discovery Market - Germany
- 8.4.6.1. Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.6.2. Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.6.3. Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.7. Antibody Discovery Market - Italy
- 8.4.7.1. Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.7.2. Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.7.3. Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.8. Antibody Discovery Market - Spain
- 8.4.8.1. Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.8.2. Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.8.3. Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.9. Antibody Discovery Market - Netherlands
- 8.4.9.1. Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.9.2. Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.9.3. Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.10. Antibody Discovery Market - Russia
- 8.4.10.1. Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.10.2. Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.10.3. Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.4.11. Antibody Discovery Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.4.11.2. Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.4.11.3. Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5. Antibody Discovery Market - Asia Pacific
- 8.5.1. Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.2. Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.3. Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.4. Antibody Discovery Market - China
- 8.5.4.1. China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.4.2. China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.4.3. China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.5. Antibody Discovery Market - India
- 8.5.5.1. India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.5.2. India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.5.3. India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.6. Antibody Discovery Market - Malaysia
- 8.5.6.1. Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.6.2. Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.6.3. Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.7. Antibody Discovery Market - Japan
- 8.5.7.1. Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.7.2. Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.7.3. Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.8. Antibody Discovery Market - Indonesia
- 8.5.8.1. Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.8.2. Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.8.3. Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.9. Antibody Discovery Market - South Korea
- 8.5.9.1. South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.9.2. South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.9.3. South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.10. Antibody Discovery Market - Australia
- 8.5.10.1. Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.10.2. Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.10.3. Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.5.11. Antibody Discovery Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.5.11.2. Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.5.11.3. Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6. Antibody Discovery Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.2. Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.3. Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.4. Antibody Discovery Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.4.2. Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.4.3. Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.5. Antibody Discovery Market - UAE
- 8.6.5.1. UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.5.2. UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.5.3. UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.6. Antibody Discovery Market - Israel
- 8.6.6.1. Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.6.2. Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.6.3. Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.7. Antibody Discovery Market - South Africa
- 8.6.7.1. South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.7.2. South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.7.3. South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.6.8. Antibody Discovery Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.6.8.2. Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.6.8.3. Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7. Antibody Discovery Market - Latin America
- 8.7.1. Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.7.2. Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.7.3. Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.4. Antibody Discovery Market - Mexico
- 8.7.4.1. Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.7.4.2. Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.7.4.3. Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.5. Antibody Discovery Market - Brazil
- 8.7.5.1. Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.7.5.2. Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.7.5.3. Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.6. Antibody Discovery Market - Argentina
- 8.7.6.1. Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.7.6.2. Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.7.6.3. Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
- 8.7.7. Antibody Discovery Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
- 8.7.7.2. Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
- 8.7.7.3. Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Biocytogen
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Method Benchmarking
- 10.1.4. Recent Development
- 10.2. Charles River Laboratories
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Method Benchmarking
- 10.2.4. Recent Development
- 10.3. Creative Biolabs
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Method Benchmarking
- 10.3.4. Recent Development
- 10.4. Danaher Corporation
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Method Benchmarking
- 10.4.4. Recent Development
- 10.5. Eurofins Scientific
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Method Benchmarking
- 10.5.4. Recent Development
- 10.6. Evotec
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Method Benchmarking
- 10.6.4. Recent Development
- 10.7. Fairjourney Biologics S.A
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Method Benchmarking
- 10.7.4. Recent Development
- 10.8. Genscript Technology Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Method Benchmarking
- 10.8.4. Recent Development
- 10.9. Sartorius AG
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Method Benchmarking
- 10.9.4. Recent Development
- 10.10. Twist Bioscience
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Method Benchmarking
- 10.10.4. Recent Development
